In humans, peripheral blood eosinophilia often occurs when immunotherapy with interleukin (IL)-2 [33, 34], IL-4 [35], granulocyte macrophage colony-stimulating factor [36], or tumor vaccine is performed [37]. This evidence concerns the gene IL4 and neoplasm.